LSE - Delayed Quote GBp

Hemogenyx Pharmaceuticals Plc (HEMO.L)

178.75
-0.25
(-0.14%)
At close: May 14 at 5:15:00 PM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
1,301.69
1,301.69
1,692.20
2,196.82
283.65
Gross Profit
-1,301.69
-1,301.69
-1,692.20
-2,196.82
-283.65
Operating Expense
4,425
4,425
3,866.35
3,333.67
2,546.98
Operating Income
-5,726.69
-5,726.69
-5,558.55
-5,530.49
-2,830.62
Net Non Operating Interest Income Expense
-248.39
-248.39
-230.65
10.57
-2,577.43
Pretax Income
-5,625.48
-5,625.48
-6,696.49
-3,986.98
-5,108.31
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-5,619.18
-5,619.18
-6,690.68
-3,979.31
-5,099.23
Diluted NI Available to Com Stockholders
-5,619.18
-5,619.18
-6,690.68
-3,979.31
-5,099.23
Basic EPS
-2.00
-1.70
-2.37
-2.00
-2.80
Diluted EPS
-2.00
-1.70
-2.37
-2.00
-2.80
Basic Average Shares
3,052.81
3,301.43
2,822.84
2,449.37
1,934.88
Diluted Average Shares
3,052.81
3,301.43
2,822.84
2,449.37
1,934.88
Total Operating Income as Reported
-5,377.09
-5,377.09
-6,465.85
-3,997.55
-2,702.75
Rent Expense Supplemental
0
--
--
--
--
Total Expenses
5,726.69
5,726.69
5,558.55
5,530.49
2,830.62
Net Income from Continuing & Discontinued Operation
-5,619.18
-5,619.18
-6,690.68
-3,979.31
-5,099.23
Normalized Income
-5,619.18
-5,619.18
-6,690.68
-3,979.31
-5,271.10
Interest Income
23.16
23.16
85.34
10.60
17.96
Interest Expense
271.56
271.56
315.99
0.03
2,595.39
Net Interest Income
-248.39
-248.39
-230.65
10.57
-2,577.43
EBIT
-5,353.92
-5,353.92
-6,380.50
-3,986.95
-2,512.92
EBITDA
-4,714.64
-4,714.64
-5,734.82
-3,422.88
-2,386.58
Reconciled Cost of Revenue
1,301.69
1,301.69
1,692.20
2,196.82
283.65
Reconciled Depreciation
639.29
639.29
645.68
195.25
126.34
Net Income from Continuing Operation Net Minority Interest
-5,619.18
-5,619.18
-6,690.68
-3,979.31
-5,099.23
Total Unusual Items Excluding Goodwill
--
--
--
--
171.88
Total Unusual Items
--
--
--
--
171.88
Normalized EBITDA
-4,714.64
-4,714.64
-5,734.82
-3,422.88
-2,558.46
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/9/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6C1.SG CytomX Therapeutics Inc
2.0420
-1.54%
 
N04.MU Nucana PLC R
0.0405
+19.12%
 
6C1.BE CytomX Therapeutics Inc
2.0680
-1.43%
 
0A45.IL Moderna, Inc.
24.45
-3.83%
 
226950.KQ OliX Pharmaceuticals, Inc
46,300.00
+4.75%
 
N04.SG Nucana PLC (ADRs)
0.0280
+7.69%
 
N04.F NuCana plc
0.0100
0.00%
 
6C1.F CytomX Therapeutics, Inc.
2.0700
+0.88%
 
PYC.L Physiomics Plc
0.4250
-1.16%
 
VAL.L ValiRx plc
0.5250
0.00%